GRI Bio, Inc. (GRI)

NASDAQ: GRI · IEX Real-Time Price · USD
0.776
+0.024 (3.12%)
At close: Mar 27, 2024, 4:00 PM
0.768
-0.008 (-1.06%)
Pre-market: Mar 28, 2024, 7:33 AM EDT

Total Valuation

GRI Bio has a market cap or net worth of $746,782. The enterprise value is -$2.71 million.

Market Cap 746,782
Enterprise Value -2.71M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

GRI Bio has 976,186 shares outstanding. The number of shares has increased by 360.26% in one year.

Shares Outstanding 976,186
Shares Change (YoY) +360.26%
Shares Change (QoQ) +70.59%
Owned by Insiders (%) 17.75%
Owned by Institutions (%) 4.60%
Float 367,144

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.34
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.01.

Current Ratio 2.01
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -13.52

Financial Efficiency

Return on equity (ROE) is -1,101.40% and return on invested capital (ROIC) is -536.90%.

Return on Equity (ROE) -1,101.40%
Return on Assets (ROA) -410.70%
Return on Capital (ROIC) -536.90%
Revenue Per Employee n/a
Profits Per Employee -$12.86M
Employee Count 1
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.07% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -99.07%
50-Day Moving Average 1.21
200-Day Moving Average 11.03
Relative Strength Index (RSI) 35.62
Average Volume (30 Days) 740,344

Short Selling Information

The latest short interest is 115,733, so 11.86% of the outstanding shares have been sold short.

Short Interest 115,733
Short Previous Month 143,419
Short % of Shares Out 11.86%
Short % of Float 31.52%
Short Ratio (days to cover) 0.08

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -12.11M
Pretax Income -12.86M
Net Income -12.86M
EBITDA -11.97M
EBIT -11.98M
Earnings Per Share (EPS) -$81.48
Full Income Statement

Balance Sheet

The company has $3.49 million in cash and $28,000 in debt, giving a net cash position of $3.46 million or $3.54 per share.

Cash & Cash Equivalents 3.49M
Total Debt 28,000
Net Cash 3.46M
Net Cash Per Share $3.54
Equity / Book Value 2.23M
Book Value Per Share 2.28
Working Capital 2.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$4.80 million and capital expenditures -$8,000, giving a free cash flow of -$4.81 million.

Operating Cash Flow -4.80M
Capital Expenditures -8,000
Free Cash Flow -4.81M
FCF Per Share -$8.16
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -360.26%
Shareholder Yield -360.26%
Earnings Yield -1,722.32%
FCF Yield -643.96%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on January 30, 2024. It was a reverse split with a ratio of 1:7.

Last Split Date Jan 30, 2024
Split Type Reverse
Split Ratio 1:7

Scores

Altman Z-Score n/a
Piotroski F-Score 1